484.96
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $484.96, with a volume of 3.41M.
It is up +1.39% in the last 24 hours and up +18.78% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$478.32
Open:
$475.44
24h Volume:
3.41M
Relative Volume:
1.21
Market Cap:
$183.07B
Revenue:
$43.21B
Net Income/Loss:
$6.58B
P/E Ratio:
28.05
EPS:
17.29
Net Cash Flow:
$6.17B
1W Performance:
+19.76%
1M Performance:
+18.78%
6M Performance:
-17.00%
1Y Performance:
-20.12%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TMO
Thermo Fisher Scientific Inc
|
484.96 | 180.56B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
202.94 | 147.13B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
566.50 | 45.45B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
119.54 | 34.14B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
197.76 | 33.86B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
Jul-09-25 | Downgrade | UBS | Buy → Neutral |
Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
Dec-23-24 | Initiated | Scotiabank | Sector Perform |
Oct-14-24 | Initiated | Redburn Atlantic | Buy |
Oct-01-24 | Initiated | Stephens | Overweight |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jun-03-24 | Resumed | Jefferies | Buy |
Mar-18-24 | Resumed | Citigroup | Neutral |
Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
Dec-18-23 | Initiated | HSBC Securities | Buy |
Dec-13-23 | Initiated | Wolfe Research | Outperform |
Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Sep-28-23 | Initiated | Bernstein | Outperform |
Sep-06-23 | Resumed | Citigroup | Buy |
Jul-19-23 | Initiated | Raymond James | Outperform |
Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
Apr-04-23 | Reiterated | Barclays | Overweight |
Dec-14-22 | Initiated | Deutsche Bank | Buy |
Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Jan-26-22 | Resumed | Barclays | Overweight |
Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
Oct-15-21 | Resumed | Cowen | Outperform |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Jul-16-21 | Initiated | The Benchmark Company | Buy |
Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-03-21 | Initiated | Barclays | Overweight |
Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
Dec-02-20 | Initiated | Goldman | Buy |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-30-20 | Initiated | Atlantic Equities | Overweight |
Sep-14-20 | Initiated | Morgan Stanley | Overweight |
Aug-20-20 | Resumed | JP Morgan | Overweight |
Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
Jul-07-20 | Reiterated | Needham | Buy |
Apr-23-20 | Reiterated | Needham | Buy |
Jan-31-20 | Reiterated | Needham | Buy |
Jan-22-20 | Initiated | Credit Suisse | Neutral |
Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Buy |
Jul-25-19 | Reiterated | Needham | Buy |
Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
May-30-19 | Initiated | Wolfe Research | Outperform |
May-23-19 | Reiterated | Needham | Strong Buy |
Apr-22-19 | Reiterated | Needham | Strong Buy |
Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - GlobeNewswire Inc.
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid market shifts - Investing.com
COVID-19 Saliva-Based Detection Kits Market to reach US$ 1.2 Bn - openPR.com
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025 - Bluefield Daily Telegraph
Cell Reprogramming Market Future Business Opportunities - openPR.com
Thermo Fisher Scientific's (TMO) Q2 Outperformance and Revised Price Target: Is Now the Time to Buy? - AInvest
Refurbished Laboratory Equipment Market Top Companies Study - openPR.com
Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450 - Insider Monkey
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth - Insider Monkey
When is Thermo Fisher Scientific Inc. stock expected to show significant growthDiscover high-impact investment opportunities - jammulinksnews.com
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
Thermo Fisher Scientific Inc. (TMO) Has Finally Got It Together, Says Jim Cramer - MSN
Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480 - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentFree Stock Index Interpretation - PrintWeekIndia
Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference - Yahoo Finance
Fortune 500 Power Moves: Which executives gained and lost power this week, July 19-25, 2025 - Fortune
Thermo Fisher Unit Can’t Undo Executive’s $24 Million Bias Win - Bloomberg Law News
Analyst recommendations: Thermo Fisher Scientific, Intel, Honeywell International, Union Pacific, Gilead Sciences... - MarketScreener
Thermo Fisher Scientific Second Quarter 2025 Earnings: Beats Expectations - simplywall.st
Microplate Readers Market Is Booming So Rapidly 2025-2032 - openPR.com
Thermo Fisher Scientific Increases Accessibility to Research with the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - AZoM
ICP-MS System Market Key Players AnalysisPerkinElmer, Inc., - openPR.com
Stifel lowers Thermo Fisher Scientific stock price target to $583 on mixed outlook - Investing.com Canada
What analysts say about Thermo Fisher Scientific Inc. stock outlookRapid wealth multiplication - jammulinksnews.com
HSBC downgrades Thermo Fisher Scientific stock to Hold on growth concerns - Investing.com
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - StreetInsider
Thermo Fisher Scientific Inc. Ranks 19th in Trading Volume Despite 17.31% Stock Gain in Three Days - AInvest
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
UBS Maintains Neutral Rating for Thermo Fisher, Raises PT to $500 from $460 - AInvest
Thermo Fisher Scientific shares rise 2.73% intraday after announcing new electron microscopes and licensing agreement expansion. - AInvest
Thermo Fisher CFO to retire after decade, internal successor named - The Business Journals
Bernstein raises Thermo Fisher Scientific stock price target on pharma R&D strength - Investing.com
Analyst recommendations: Alphabet, IBM, Thermo Fisher Scientific, Lockheed Martin, ServiceNow... - MarketScreener
Thermo Fisher Scientific Inc. (NYSE:TMO) Q2 2025 Earnings Call Transcript - Insider Monkey
Thermo Fisher Scientific Q2 2025 revenue up 3% to USD 10.85B - Medical Buyer
Company News for Jul 24, 2025 - The Globe and Mail
Research Alert: CFRA Keeps Buy Recommendation On Shares Of Thermo Fisher Scientific Inc. - 富途牛牛
Thermo Fisher Scientific Inc (TMO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026 - BioSpace
Thermo Fisher Scientific Reports Steady Q2 2025 Growth - TipRanks
Thermo Fisher Scientific's Revised Outlook: A Catalyst for Long-Term Growth in Life Sciences and Diagnostics - AInvest
Thermo Fisher: Q2 Earnings Snapshot - Norwalk Hour
Thermo Fisher Scientific's Q3 2025 Earnings: Assessing Growth Sustainability Amid Life Sciences Surge - AInvest
Thermo Fisher Q2 Revenue Exceeds Estimates, Shares Surge 12% Amid Strong Life Sciences and Diagnostics Demand - AInvest
Thermo Fisher’s Earnings Call Highlights Growth and Challenges - TipRanks
Thermo Fisher Scientific announces CFO retirement and successor appointment - Investing.com
Thermo Fisher Announces CFO Retirement and Successor - TipRanks
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
TMO announces CFO retirement & internal successor effective 2026 | TMO SEC FilingForm 8-K - Stock Titan
Why Thermo Fischer Stock Is Rising Wednesday - AOL.com
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):